Zepto Life Launches FungiFlex Tests for Rapid Fungal Diagnosis
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
BASEL, Switzerland, July 6, 2026 Novartis has announced a landmark agreement to acquire Myricx Bio, a UK-based biotechnology company...
CARLSBAD, California, July 2, 2026 Arima Genomics, Inc., a cancer diagnostics company advancing precision oncology through Hi-C sequencing technology,...
SAN DIEGO, Calif., June 3, 2026 Zepto Life Technology has achieved a significant regulatory milestone after receiving U.S. Food...
IRVING, Texas, May 8, 2026 Caris Life Sciences® has submitted an application to the New York State Department of...
